AP1S2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.496600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.858300E-02
Normal-vs-Stage2
5.177300E-03
Normal-vs-Stage3
1.791800E-02
Normal-vs-Stage4
5.935700E-02
Stage1-vs-Stage2
9.958200E-01
Stage1-vs-Stage3
5.353400E-01
Stage1-vs-Stage4
9.960200E-01
Stage2-vs-Stage3
5.435000E-01
Stage2-vs-Stage4
9.922400E-01
Stage3-vs-Stage4
5.774000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.342800E-03
Normal-vs-AfricanAmerican
7.610200E-02
Normal-vs-Asian
8.461500E-03
Caucasian-vs-AfricanAmerican
6.006000E-01
Caucasian-vs-Asian
1.941970E-01
AfricanAmerican-vs-Asian
2.368400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.915080E-03
Normal-vs-Female
1.931640E-02
Male-vs-Female
3.013600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.945800E-02
Normal-vs-Age(41-60Yrs)
2.768500E-02
Normal-vs-Age(61-80Yrs)
3.943400E-03
Normal-vs-Age(81-100Yrs)
1.879970E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.518200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.323600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.351800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.995600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.427560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.244800E-04
Normal-vs-Daily Drinker
1.191600E-04
Normal-vs-Weekly Drinker
6.583800E-02
Normal-vs-Occasional Drinker
5.243500E-03
Normal-vs-Social Drinker
1.286020E-01
Non Drinker-vs-Daily Drinker
4.900000E-01
Non Drinker-vs-Weekly Drinker
3.323600E-01
Non Drinker-vs-Occasional Drinker
7.456200E-01
Non Drinker-vs-Social Drinker
1.924010E-01
Daily Drinker-vs-Weekly Drinker
2.249400E-01
Daily Drinker-vs-Occasional Drinker
3.572400E-01
Daily Drinker-vs-Social Drinker
9.666400E-02
Weekly Drinker-vs-Occasional Drinker
5.520800E-01
Weekly Drinker-vs-Social Drinker
6.769000E-01
Occasional Drinker-vs-Social Drinker
2.801600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.729800E-01
Normal-vs-Grade 2
7.577200E-01
Normal-vs-Grade 3
7.136200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.451800E-01
Grade 1-vs-Grade 3
2.436800E-01
Grade 1-vs-Grade 4
7.729800E-01
Grade 2-vs-Grade 3
1.819990E-01
Grade 2-vs-Grade 4
7.577200E-01
Grade 3-vs-Grade 4
7.136200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.398700E-03
Normal-vs-NonDiabetic
4.019800E-03
Diabetic-vs-NonDiabetic
8.756000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.490000E-02
Normal-vs-NoPancreatitis
3.977600E-03
Pancreatitis-vs-NoPancreatitis
5.299600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.125790E-02
Normal-vs-N1
4.922400E-03
N0-vs-N1
9.532000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.078150E-03
Normal-vs-TP53-NonMutant
4.016300E-02
TP53-Mutant-vs-TP53-NonMutant
6.404500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
